How big is the biochips market today, and what are its future growth expectations?
The biochips market size has grown rapidly in recent years. It will grow from $12.62 billion in 2024 to $14.72 billion in 2025 at a compound annual growth rate (CAGR) of 16.6%. The growth in the historic period can be attributed to increased demand for personalized medicine, high prevalence of chronic diseases, technological innovations, expanded applications in drug discovery, growth in investments in research and development, and supportive regulatory frameworks.
The biochips market size is expected to see rapid growth in the next few years. It will grow to $26.94 billion in 2029 at a compound annual growth rate (CAGR) of 16.3%. The growth in the forecast period can be attributed to increasing adoption in point-of-care diagnostics, expanding applications in drug development, rising demand for personalized medicine, advancements in microfluidics technology, growing investments in research and development, expanding collaborations between biotechnology companies and academic institutions, and emerging opportunities in agricultural biotechnology. Major trends in the forecast period include advancements in microfluidics technology, emphasis on developing biochips for liquid biopsy applications, rising demand for multiplexed assays for simultaneous detection of multiple analytes, integration of artificial intelligence for data analysis, and the emergence of novel biochip platforms.
Get Your Free Sample of The Global Biochips Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15737&type=smp
What have been the primary factors driving the biochips market’s growth?
The increasing adoption of personalized medicines is expected to propel the growth of the biochips market going forward. Personalized medicine refers to tailoring medical treatment to individual characteristics, such as genetics or lifestyle, to optimize effectiveness and minimize adverse effects. The growing demand for personalized medicine is driven by its potential to provide more effective treatments, advancements in genomics, increasing disease complexity, and regulatory support. Biochips aid in personalized medicine by allowing for precise and individualized treatment plans tailored to a person’s genetic profile. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Thus, the increasing adoption of personalized medicines is driving the growth of the biochips market.
What are the key segments within the biochips market?
The biochips market covered in this report is segmented –
1) By Type: Deoxyribonucleic Acid (DNA) Chips, Protein Chips, Lab-On-Chip, Tissue Arrays, Cell Arrays
2) By Technology: Microarrays, Microfluidics
3) By Application: Drug Discovery And Development, Agriculture, Genomics, Disease Diagnostics, Proteomics, Other Applications
4) By End-User: Biotechnology And Pharmaceutical Companies, Academic And Research Institutes, Hospitals And Diagnostic Centers, Other End-Users
Subsegments:
1) By Deoxyribonucleic Acid (Dna) Chips: Gene Expression Chips, Snp (Single Nucleotide Polymorphism) Chips, Dna Microarrays
2) By Protein Chips: Antibody Arrays, Protein Microarrays, Peptide Arrays
3) By Lab-On-Chip: Microfluidic Devices, Biosensors
4) By Tissue Arrays: Tumor Tissue Arrays, Normal Tissue Arrays
5) By Cell Arrays: Cell-Based Biochips, Cell Signaling Arrays
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/biochips-global-market-report
Which key players are shaping the biochips market?
Major companies operating in the biochips market are Thermo Fisher Scientific Inc., Roche Diagnostics International Ltd., Zoetis Inc., Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Group Ltd., Cepheid Inc., Randox Laboratories Ltd., Takara Bio Inc., Oxford Nanopore Technologies plc, Luminex Corporation, Fluidigm Corporation, Micronit Microtechnologies B.V., Sphere Fluidics Limited, Sengenics, Arrayit Corporation, CustomArray Inc., Partek Incorporated, NanoCellect Biomedical Inc., Dolomite Microfluidics, Biocartis NV
How will emerging trends drive the biochips market throughout the forecast period?
Major companies in the biochips market are concentrating their efforts on developing cutting-edge technologies like organ-on-a-chip platforms, aiming to revolutionize drug discovery and development processes. Organ-on-a-chip platforms are advanced microfluidic devices engineered to replicate the physiological characteristics and functions of human organs in a scaled-down format. For instance, in April 2024, Boston Micro Fabrication (BMF), a US-based nanotechnology research company, launched BMF Biotechnology Inc. BMF Biotechnology Inc. specializes in Biochips, also known as organ-on-a-chip platforms, designed to cultivate large-scale tissues in vitro. This innovation facilitates the accelerated development of new drugs and cosmetics by providing a platform for testing and research outside of the human body.
How do regional factors impact the biochips market, and which region is the largest contributor?
North America was the largest region in the biochips market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biochips market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Biochips Market Report 2025 Offer?
The biochips market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Biochips are miniaturized devices containing an array of biological molecules, such as deoxyribonucleic acid (DNA), proteins, or cells, immobilized on a solid substrate. They combine biological elements with electronic systems to examine and handle biological data and are commonly used in medical diagnostics, genetic sequencing, and other biotechnological fields.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15737
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
